A community based seroprevalence of SARS-CoV-2 antibodies in Somali Region, Eastern Ethiopia

被引:0
|
作者
Yared, Solomon [1 ]
Abera, Tsegalem [2 ,7 ]
Ali, Seid Mohammed [3 ,4 ]
Muhummed, Abdifatah Muktar [4 ,5 ]
Ibrahim, Mohammed [2 ]
Hassan, Abdullahi [5 ]
Hattendorf, Jan [4 ]
Zinsstag, Jakob [4 ]
Tschopp, Rea [4 ,6 ]
机构
[1] Jigjiga Univ, Dept Biol, Coll Nat & Computat Sci, Jigjiga, Ethiopia
[2] Jigjiga Univ, Coll Vet Med, Dept Vet Microbiol & Publ Hlth, Jigjiga, Ethiopia
[3] Jigjiga Univ, Dept Anim & Range Sci, Coll Dryland Agr, Jigjiga, Ethiopia
[4] Univ Basel, Dept Epidemiol & Publ Hlth, Basel, Switzerland
[5] Jigjiga Univ, Coll Med & Hlth Sci, Sch Med, Jigjiga, Ethiopia
[6] Armauer Hansen Res Inst, One Hlth Unit, Addis Ababa, Ethiopia
[7] Jigjiga Univ, Coll Vet Med, Dept Vet Microbiol & Publ Hlth, POB 1020, Jigjiga, Ethiopia
关键词
community; SARS-CoV-2; seroprevalence; Somali Region; COVID-19;
D O I
10.1002/iid3.1148
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundCoronavirus disease 19 (COVID-19) is life-threatening infectious disease caused by SARS-CoV-2 virus that caused a global pandemic. SARS-CoV-2 has been widely transmitted throughout Ethiopia, with over 501,060 cases confirmed and 7574 deaths until November 2023. This study assessed for the first time the seroprevalence SARS-CoV-2 in the general population of the Somali Region during the COVID-19 pandemic.MethodsA cross-sectional study design was conducted from May to June 2021 in 14 districts of Somali Region. Blood samples were collected in 820 participants in addition to administering a questionnaire that included sociodemographic characteristics and history of clinical symptoms of COVID-19. Blood samples were tested for the presence or absence of anti-SARS-CoV-2 using a commercial Enzyme-Linked Immunosorbent Assay (ELISA) kit (Euroimmun).ResultsOverall, 477 (58.2%) were male and 343 (41.8%) were female. The majority of the participants (N = 581; 70.9%) were between 18 and 34 years old and not vaccinated against COVID-19 (N = 793; 96.7%). The overall seroprevalence of SARS-CoV-2 antibodies was 41.7% (95% CI: 33.3%-47.6%). The highest prevalence was found in Goljano district (70%) and the lowest in Gunagado district (22.5%). Only age was found to be associated with COVID-19 seropositivity.ConclusionPrevalence of SARS-CoV-2 antibodies was the highest ever reported in Ethiopia, indicating that a large proportion of the population had been infected 14 months after the start of the outbreak in the country. Such studies are important to swiftly reassess and improve specific COVID-19 preventive and control measures to reduce transmissions within the community in a given setting. We conducted a cross-sectional study to estimate the seroprevalence of antibodies to SARS-CoV-2 in 820 participants from the general population of SRS during the COVID-19 pandemic and risk factors for disease and disease transmission The overall seroprevalence of COVID-19 was 41.7% (95% CI: 33.3%-47.6%). The highest prevalence was found in Goljano district (70%) and the lowest in Gunagado district (22.5%). Only age was found to be significantly associated with COVID-19 seropositivity. The high prevalence of COVID-19 combined with the low vaccination rate indicated that a large proportion of the population in SRS had been infected since the beginning of 2020 The key findings from the present study will have implications for shaping future epidemic control.image
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study
    de Souza Araujo, Adriano Antunes
    Quintans-Junior, Lucindo Jose
    Heimfarth, Luana
    Schimieguel, Dulce Marta
    Correa, Cristiane Bani
    de Moura, Tatiana Rodrigues
    Cavalcante, Rafael Ciro Marques
    Rodrigues Bomfim, Rangel
    Grespan, Renata
    Santana Rodrigues, Lorranny
    dos Santos, Danillo Menezes
    de Sa Resende, Ayane
    de Lima Silva, Nathanielly
    da Silva Santos, Anna Clara Ramos
    Dantas Araujo, Jessica Maria
    de Souza, Mercia Feitosa
    de Oliveira Goes, Marco Aurelio
    Santana Santos, Victor
    Martins-Filho, Paulo Ricardo
    EPIDEMIOLOGY AND INFECTION, 2021, 149
  • [22] Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection
    Bhuiyan, Taufiqur Rahman
    Akhtar, Marjahan
    Akter, Aklima
    Khaton, Fatema
    Rahman, Sadia Isfat Ara
    Ferdous, Jannatul
    Nazneen, Arifa
    Sumon, Shariful Amin
    Banik, Kajal C.
    Bablu, Arifur Rahman
    Alamgir, A. S. M.
    Rahman, Mahbubur
    Tony, Selim Reza
    Hossain, Khaled
    Calderwood, Stephen B.
    Charles, Richelle C.
    Ryan, Edward T.
    LaRocque, Regina C.
    Harris, Jason B.
    Rahman, Mustafizur
    Chakraborty, Nitai
    Rahman, Mahmudur
    El Arifeen, Shams
    Flora, Meerjady Sabrina
    Shirin, Tahmina
    Banu, Sayera
    Qadri, Firdausi
    IJID REGIONS, 2022, 2 : 198 - 203
  • [23] Silent SARS-CoV-2 infection: seroprevalence study of SARS-CoV-2 anti- nucleocapsid IgG antibodies in Kragujevac, Serbia
    Cicaric, Neda
    Canovic, Vanja
    Stojkovic, Milica
    Matic, Sanja
    Stefanovic, Srdjan
    Popovic, Suzana
    Todorovic, Danijela
    Djordjevic, Natasa
    Radenkovic, Biljana
    Radenkovic, Marko
    Antic, Vasilije
    Baskic, Dejan
    ACTA VIROLOGICA, 2023, 67
  • [24] Seroprevalence and placental transfer of SARS-CoV-2 antibodies in unvaccinated pregnant women
    Vercoutere, An
    Zina, Mbiton Joel
    Telis, Meltem
    Goffard, Jean-Christophe
    Boulvain, Michel
    de Doncker, Loic
    Derisbourg, Sara
    Houben, Sylvie
    Delforge, Marie-Luce
    Daelemans, Caroline
    Kelen, Dorottya
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [25] Study of seroprevalence of SARS-CoV-2 in Kazakhstan
    Kulimbet, Mukhtar
    Saliev, Timur
    Alimbekova, Gulzhan
    Ospanova, Dinara
    Tobzhanova, Kundyzay
    Tanabayeva, Dariga
    Zhussupov, Baurzhan
    Fakhradiyev, Ildar
    EPIDEMIOLOGY & INFECTION, 2023, 151
  • [26] Nationwide retrospective mortality and seroprevalence of SARS-CoV-2 antibodies in Cameroon
    Eyong, J.
    Fai, K. N.
    Nikolay, B.
    Gignoux, E.
    Nsaibirni, R.
    Buri, D.
    Yuya, F.
    Youm, E.
    Ntone, R.
    Mbarga, N. F.
    Matchim, L.
    Tchiasso, D.
    Ngosso, A.
    Nanda, E.
    Yonta, C.
    Ndifon, M.
    Essomba, R. G.
    Wanda, F.
    Mandeng, N.
    Essaka, R.
    Koku, M. T.
    Eyangoh, S.
    Ousman, M.
    Esso, L.
    Epee, E.
    Njouom, R.
    Okom, M. C. A.
    Ciglenecki, I.
    Mballa, G. A.
    Issoufou, S.
    Porten, K.
    Boum, Y.
    SCIENTIFIC AFRICAN, 2023, 22
  • [27] Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024
    Louise M. Cremer
    Jannik Stemler
    Rosanne Sprute
    Sebastian Herrmann
    Theresa Markus
    Jon Salmanton-García
    Lutz Gieselmann
    Veronica Di Cristanziano
    Henning Gruell
    Oliver A. Cornely
    Sibylle C. Mellinghoff
    Blood Research, 2025, 60 (1)
  • [28] Community SARS-CoV-2 seroprevalence before and after the second wave of SARS-CoV-2 infection in Harare, Zimbabwe
    Fryatt, Arun
    Simms, Victoria
    Bandason, Tsitsi
    Redzo, Nicol
    Olaru, Ioana D.
    Ndhlovu, Chiratidzo E.
    Mujuru, Hilda
    Rusakaniko, Simbarashe
    Hoelscher, Michael
    Rubio-Acero, Raquel
    Paunovic, Ivana
    Wieser, Andreas
    Chonzi, Prosper
    Masunda, Kudzai
    Ferrand, Rashida A.
    Kranzer, Katharina
    ECLINICALMEDICINE, 2021, 41
  • [29] Estimating SARS-CoV-2 seroprevalence
    Rosin, Samuel P.
    Shook-Sa, Bonnie E.
    Cole, Stephen R.
    Hudgens, Michael G.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2023, 186 (04) : 834 - 851
  • [30] Seroprevalence of anti-SARS-CoV-2 antibodies in women attending antenatal care in eastern Ethiopia: a facility-based surveillance
    Assefa, Nega
    Regassa, Lemma Demissie
    Teklemariam, Zelalem
    Oundo, Joseph
    Madrid, Lola
    Dessie, Yadeta
    Scott, J. A. G.
    BMJ OPEN, 2021, 11 (11):